XJSECLS
Market cap4.97bUSD
Dec 20, Last price
38,585.00ZAR
1D
1.51%
1Q
-0.67%
Jan 2017
234.07%
Name
Clicks Group Ltd
Chart & Performance
Profile
Clicks Group Limited, together with its subsidiaries, operates as a health and beauty retailer, and pharmaceutical distributor and wholesaler in South Africa. The company operates in two segments, Retail and Distribution. It retails pharmacy, health and beauty through approximately 840 stores, and 620 in-store pharmacies for the middle to upper income markets under the Clicks name. The company also retails specialty health and wellness products, including vitamins, mineral and herbal supplements, sports nutrition, and slimming products under the General Nutrition Corporation (GNC) name; luxury toiletries, cosmetics, gifting, and grooming products under The Body Shop name; and fashionable jewelry and accessories for young women and girls under the Claire's name. In addition, it is involved in the wholesale and supply of pharmaceutical products to retail pharmacies, private hospitals, dispensing doctors, and retail health stores under the UPD name. The company was formerly known as New Clicks Holdings Limited and changed its name to Clicks Group Limited in June 2009. Clicks Group Limited was founded in 1968 and is based in Cape Town, South Africa.
Valuation
Title ZAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑08 | 2023‑08 | 2022‑08 | 2021‑08 | 2020‑08 | 2019‑08 | 2018‑08 | 2017‑08 | 2016‑08 | 2015‑08 | |
Income | ||||||||||
Revenues | 48,519,942 16.57% | 41,621,681 5.14% | 39,587,142 6.02% | |||||||
Cost of revenue | 36,486,541 | 32,307,830 | 31,240,694 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 12,033,401 | 9,313,851 | 8,346,448 | |||||||
NOPBT Margin | 24.80% | 22.38% | 21.08% | |||||||
Operating Taxes | 1,056,751 | 933,577 | 1,000,468 | |||||||
Tax Rate | 8.78% | 10.02% | 11.99% | |||||||
NOPAT | 10,976,650 | 8,380,274 | 7,345,980 | |||||||
Net income | 2,837,057 11.80% | 2,537,528 -3.83% | 2,638,680 43.57% | |||||||
Dividends | (1,562,794) | (1,286,940) | ||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (834,790) | (703,520) | 1,720,880 | |||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 1,249,585 | (966,013) | 1,012,159 | |||||||
Long-term debt | 6,322,987 | 5,391,410 | 5,187,609 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 150,855 | 117,907 | 129,854 | |||||||
Net debt | 4,527,964 | 1,655,004 | 3,828,888 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 3,006,144 | 3,310,073 | 1,917,075 | |||||||
CAPEX | (890,860) | (930,004) | (837,599) | |||||||
Cash from investing activities | (913,899) | (1,210,934) | (784,015) | |||||||
Cash from financing activities | (1,842,460) | (1,658,516) | (1,325,134) | |||||||
FCF | 11,078,586 | 10,538,458 | 3,475,533 | |||||||
Balance | ||||||||||
Cash | 2,704,961 | 2,455,176 | 2,014,553 | |||||||
Long term investments | 339,647 | 315,217 | 356,327 | |||||||
Excess cash | 618,611 | 689,309 | 391,523 | |||||||
Stockholders' equity | (19,934) | 4,899,861 | 4,633,854 | |||||||
Invested Capital | 10,242,614 | 8,632,337 | 8,346,959 | |||||||
ROIC | 116.31% | 98.71% | 95.04% | |||||||
ROCE | 117.55% | 99.92% | 95.28% | |||||||
EV | ||||||||||
Common stock shares outstanding | 238,346 | 243,460 | 244,306 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | 13,775,694 | 10,832,877 | 9,721,058 | |||||||
EV/EBITDA | ||||||||||
Interest | 355,038 | 231,580 | 210,288 | |||||||
Interest/NOPBT | 2.95% | 2.49% | 2.52% |